BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31965550)

  • 1. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
    Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
    Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
    Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
    Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
    Pienaar IS; van de Berg W
    Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
    Elson JL; Yates A; Pienaar IS
    Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
    Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
    Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat.
    Forster GL; Blaha CD
    Eur J Neurosci; 2003 Feb; 17(4):751-62. PubMed ID: 12603265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
    Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
    Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
    J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
    Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.
    Witzig VS; Alosaimi F; Temel Y; Schulz JB; Jahanshahi A; Tan SKH
    Neurosci Lett; 2023 Apr; 802():137134. PubMed ID: 36801348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
    Elson JL; Kochaj R; Reynolds R; Pienaar IS
    Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.
    Aravamuthan BR; Bergstrom DA; French RA; Taylor JJ; Parr-Brownlie LC; Walters JR
    Exp Neurol; 2008 Oct; 213(2):268-80. PubMed ID: 18601924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
    Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
    Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem.
    Dautan D; Huerta-Ocampo I; Witten IB; Deisseroth K; Bolam JP; Gerdjikov T; Mena-Segovia J
    J Neurosci; 2014 Mar; 34(13):4509-18. PubMed ID: 24671996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
    Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
    J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism.
    Masini D; Kiehn O
    Nat Commun; 2022 Jan; 13(1):504. PubMed ID: 35082287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats.
    Boekhoudt L; Omrani A; Luijendijk MC; Wolterink-Donselaar IG; Wijbrans EC; van der Plasse G; Adan RA
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1784-1793. PubMed ID: 27712862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
    Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P
    Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model.
    Saryyeva A; Nakamura M; Krauss JK; Schwabe K
    J Chem Neuroanat; 2011 Nov; 42(3):210-7. PubMed ID: 21855627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease.
    Chambers NE; Lanza K; Bishop C
    Front Pharmacol; 2019; 10():1494. PubMed ID: 32009944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.